Home » Reports » Broker Ratings » AstraZeneca plc 7.1% Potential Upside Indicated by Barclays Capital

AstraZeneca plc 7.1% Potential Upside Indicated by Barclays Capital

AstraZeneca plc using EPIC/TICKER code (LON:AZN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘OVERWEIGHT’ today by analysts at Barclays Capital. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Barclays Capital have set a target price of 7800 GBX on its stock. This now indicates the analyst believes there is a possible upside of 7.1% from the opening price of 7286 GBX. Over the last 30 and 90 trading days the company share price has increased 844 points and increased 1401 points respectively. The 52 week high share price is 7475.15 GBX while the year low share price is currently 5312 GBX.

AstraZeneca plc has a 50 day moving average of 6,686.05 GBX and the 200 Day Moving Average price is recorded at 6,209.71. There are currently 1,311,876,336 shares in issue with the average daily volume traded being 2,241,422. Market capitalisation for LON:AZN is £95,189,746,940 GBP.